Improvement in intestinal microbiota in pediatric patients with cystic fibrosis after treatment with CFTR modulators
The primary objective of this study was to characterize the changes in the intestinal microbiota of pediatric CF patients (aged 6-18 years) after six months of treatment with the triple therapy ELX/TEZ/IVA.